Priority Date: 13.06.12 (US 201261659239P)

METHYLATION BIOMARKERS FOR BREAST CANCER

  • Application ID: EP13804083
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorneys

operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing
no operation time available
1 office
active in Legal Services

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) is specialized in the combination A61 and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Zacco Denmark A/S, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB and 172 others are specialized in all of these IPC classes. For a similar patent, they might be a good choice.

Timeline

  • 13.06.2012 - Priority Date (US 201261659239P)
  • 19.12.2013 - Publication A2 (WO2013186639)
  • 22.04.2015 - Publication A2 (EP2861766)

IPC Classification